Biocept, Inc. Profile Avatar - Palmy Investing

Biocept, Inc.

Biocept, Inc., a molecular oncology diagnostics company, develops and commercializes proprietary circulating tumor cell and circulating cell-free tumor DNA and RNA assays utilizing a standard blood sample. Its cancer assays provide information to healthc…

Medical - Diagnostics & Research
US, San Diego [HQ]

Lobbying Analysis

Biocept, Inc. has no lobbying expenses in our database.

History

Download
FY Quarter Expense For Lobby Disclosure LDA Reference
No data
End of BIOC's Analysis
CIK: 1044378 CUSIP: 09072V402 ISIN: US09072V6002 LEI: - UEI: -
Secondary Listings
BIOC has no secondary listings inside our databases.